Other Events ·
Cogent Biosciences entered into a Commercial Supply Agreement with Hovione FarmaCiencia to manufacture bezuclastinib…
COGTCogent Biosciences, Inc.
Cogent Biosciences entered into a Commercial Supply Agreement with Hovione FarmaCiencia to manufacture bezuclastinib spray-dried dispersion and tablets. The company will purchase products based on rolling forecasts, committing to specified minimum percentages of its requirements that decrease over the five-year initial term, which includes automatic two-year renewals. Cogent Biosciences operates in the biotechnology industry, focusing on the development of targeted therapies for cancer.